Paper Details 
Original Abstract of the Article :
We have carried out laboratory and clinical studies on cefdinir (CFDN) 5% and 10% fine granule preparations. The results are summarized as follows. CFDN 5% fine granule preparation was given via oral route to each of 2 children in the fasting state at a single dose of 3 mg/kg. After administration, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1762170

データ提供:米国国立医学図書館(NLM)

Cefdinir: A New Path Through Pediatric Infections

This study takes us on a journey into the world of pediatric antibiotics, exploring the efficacy and safety of cefdinir, a drug used to treat various bacterial infections. The researchers, like seasoned pharmacists, conducted meticulous lab and clinical studies to evaluate the effectiveness of cefdinir in different forms and dosages for children. They meticulously charted the drug's journey through the body, analyzing its absorption, elimination, and overall impact on the child's system.

Cefdinir's Effectiveness: Navigating the Challenges of Pediatric Infections

The researchers found that cefdinir effectively tackled a range of bacterial infections, like a skilled desert explorer navigating treacherous terrain. Their meticulous analysis showcased cefdinir's efficacy in treating tonsillitis, scarlet fever, pharyngitis, impetigo, and other infections. The study's results, like a clear path through the desert, highlight the potential of cefdinir as a valuable tool in treating pediatric infections.

A Safe Oasis for Pediatric Infections

This study, like a safe oasis in the desert, underscores the importance of safety in pediatric medicine. While cefdinir showed promising results, the researchers also emphasized the need for careful monitoring of potential side effects. This cautious approach reflects the commitment to safeguarding the health of children.

Dr.Camel's Conclusion

This study offers a valuable roadmap for clinicians navigating the treatment of pediatric infections. Cefdinir emerges as a potent and effective antibiotic with a favorable safety profile, offering a promising oasis for children facing bacterial infections.
Date :
  1. Date Completed 1992-02-12
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

1762170

DOI: Digital Object Identifier

1762170

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.